Mulpleta approved in China to treatthrombocytopenia in adult patients with chronic liver disease – Eddingpharm
Shionogi announced that its Chinese license partner Eddingpharm has won regulatory approval for its thrombopoietin receptor agonist Mulpleta (lusutrombopag) in China. The drug was approved for the treatment… read more.
